Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Reynes

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Emerging Infectious Diseases|March 20, 2004
Introduction of SARS in France, March-April, 2003Jean-Claude Desenclos, Sylvie van der Werf, Isabelle Bonmarin, et al.
BMJ Open|June 14, 2019
Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort studyCarmen Lía Murall, Massilva Rahmoun, Christian Selinger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2005
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trialsMark Nelson, Keikawus Arastéh, Bonaventura Clotet, et al.
Plos Biology|January 21, 2025
Viral and immune dynamics of genital human papillomavirus infections in young women with high temporal resolutionNicolas Tessandier, Baptiste Elie, Vanina Boué, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2005
Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeksBenoit Trottier, Sharon Walmsley, Jacques Reynes, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2015
Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or bothFanny Lanternier, Seyed Alireza Mahdaviani, Elisa Barbati, et al.
International Journal of Epidemiology|February 20, 2014
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)Murielle Mary-Krause, Sophie Grabar, Laurence Lièvre, et al.
International Archives of Allergy and Immunology|December 22, 2020
Spices to Control COVID-19 Symptoms: Yes, but Not Only…Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, et al.
International Archives of Allergy and Immunology|February 10, 2021
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, et al.
Allergy|April 3, 2021
Management of anaphylaxis due to COVID-19 vaccines in the elderlyJean Bousquet, Ioana Agache, Hubert Blain, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Emerging Infectious Diseases|March 20, 2004
Introduction of SARS in France, March-April, 2003Jean-Claude Desenclos, Sylvie van der Werf, Isabelle Bonmarin, et al.
BMJ Open|June 14, 2019
Natural history, dynamics, and ecology of human papillomaviruses in genital infections of young women: protocol of the PAPCLEAR cohort studyCarmen Lía Murall, Massilva Rahmoun, Christian Selinger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2005
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trialsMark Nelson, Keikawus Arastéh, Bonaventura Clotet, et al.
Plos Biology|January 21, 2025
Viral and immune dynamics of genital human papillomavirus infections in young women with high temporal resolutionNicolas Tessandier, Baptiste Elie, Vanina Boué, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 11, 2005
Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeksBenoit Trottier, Sharon Walmsley, Jacques Reynes, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2015
Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or bothFanny Lanternier, Seyed Alireza Mahdaviani, Elisa Barbati, et al.
International Journal of Epidemiology|February 20, 2014
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)Murielle Mary-Krause, Sophie Grabar, Laurence Lièvre, et al.
International Archives of Allergy and Immunology|December 22, 2020
Spices to Control COVID-19 Symptoms: Yes, but Not Only…Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, et al.
International Archives of Allergy and Immunology|February 10, 2021
Potential Interplay between Nrf2, TRPA1, and TRPV1 in Nutrients for the Control of COVID-19Jean Bousquet, Wienczyslawa Czarlewski, Torsten Zuberbier, et al.
Allergy|April 3, 2021
Management of anaphylaxis due to COVID-19 vaccines in the elderlyJean Bousquet, Ioana Agache, Hubert Blain, et al.
Pageof 20